Table 2.
Patient characteristics.
| Patient | Gestational Age | Birth Weight (g) | AGA/SGA/LGA * | Symptomatic (S)/Asymptomatic (A) | CMV PCR in urine, blood, pharynx | Viral load in blood (copies/mL) | Hearing status | Thrombocytopenia | Petechiae | Hepatomegaly | Splenomegaly | CNS involvement | Hepatitis | Trimester of infection |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| #1 | 40 | 3,470 | AGA | A | + U, B, P | 930 | 2 | |||||||
| #2 | 39 | 3,140 | AGA | A | + U, B, P | 6,760 | 2 | |||||||
| #3 | 40 | 2,660 | SGA | A | + U, B, P | 17,190 | 2 | |||||||
| #4 | 38 | 3,250 | AGA | S | + U, B, P | 9,340 | Left SNHL | White matter abnormalities | 2 | |||||
| #5 | 40 | 2,830 | AGA | S | + U, B, P | 152,800 | White matter abnormalities, cysts, scars | 1 | ||||||
| #6 | 38 | 3,330 | AGA | A | + U, B, P | 5,604 | 1 | |||||||
| #7 | 40 | 3,700 | AGA | A | + U, B, P | 1,880 | 3 | |||||||
| #8 | 37 | 2,600 | AGA | A | + U, B, P | 431 | 3 | |||||||
| #9 | 38 | 3,240 | AGA | A | + U, B, P | 486 | 2 | |||||||
| #10 | 38 | 2,750 | AGA | A | + U, B, P | 1,820 | 2 | |||||||
| #11 | 37 | 3,250 | AGA | A | + U, B, P | 2,000 | 1 | |||||||
| #12 | 39 | 3,380 | AGA | A | + U, B, P | 17,640 | 1 | |||||||
| #13 | 40 | 3,930 | LGA | A | + U, B | # | 1 | |||||||
| #14 | 40 | 3,450 | AGA | A | + U, B, P | 9,600 | 2 | |||||||
| #15 | 38 | 2,740 | SGA | S | + U, B, P | 9,200 | Left SNHL | 2 | ||||||
| #16 | 40 | 4,220 | LGA | A | + U, B, P | 810 | 3 | |||||||
| #17 | 37 | 3,500 | LGA | S | + U, B, P | 304 | White matter abnormalities | 3 | ||||||
| #18 | 39 | 3,120 | AGA | A | + U, B, P | 5,856 | X | X | X | Subependymal pseudocysts | 1 | |||
| #19 | 39 | 2,920 | SGA | S | + U, B, P | 8,684 | 3 | |||||||
| #20 | 38 | 3,150 | AGA | A | + U, B, P | 3,753 | Lenticulostriatal vasculopathy | 1 | ||||||
| #21 | # | # | # | A | + U, B, P | 1,987 | 3 | |||||||
| #22 | 41 | 3,200 | AGA | A | + P | 0 | 2 | |||||||
| #23 | # | # | # | A | + U, P | 0 | 1 | |||||||
| #24 | 40 | 3,340 | AGA | S | + U, B, P | 31,604 | Left SNHL | Subependymal pseudocysts | 1 | |||||
| #25 | 40 | 2,800 | SGA | A | + U, B, P | 31,900 | Left SNHL | 1 | ||||||
| #26 | 40 | 3,720 | AGA | S | + U, B, P | 519 | White matter abnormalities, lenticulostriatal vasculopathy | 2 | ||||||
| #27 | # | # | # | S | + U, B, P | 3,610 | Hypotonia, seizures | # | ||||||
| #28 | 39 | 4,000 | LGA | A | + U, B, P | # | 3 | |||||||
| #29 | 36 | 2,730 | AGA | A | + U, B, P | 2,774 | 2 | |||||||
| #30 | 35 | 1,750 | <3 | S | + U, B, P and cerebrospinal fluid | 1,746,873 | Bilateral SNHL | X | 1 | |||||
| #31 | 38 | 3,670 | LGA | A | + U, B, P | 9,541 | 3 | |||||||
| #32 | 38 | 3,130 | AGA | S | + U, B, P | 3,883 | White matter abnormalities, subependymal pseudocysts | 1 | ||||||
| #33 | 38 | 2,570 | SGA | A | + U, B, P | 2,343 | 1 | |||||||
| #34 | 38 | 3,580 | AGA | S | + U, B, P | # | Subependymal pseudocysts, lenticulostriatal vasculopathy | 3 | ||||||
| #35 | 37 | 4,180 | LGA | S | + U, B, P | 774 | Bilateral SNHL | White matter abnormalities, lenticulostriatal vasculopathy | 1 | |||||
| #36 | 38 | 4,150 | LGA | A | + U, B, P | # | 1 |
#missing data.